艾炷灸肺俞募穴治疗肺虚感寒型过敏性鼻炎的临床观察

发布时间：2018-01-19 21:56

本文关键词： 过敏性鼻炎艾炷灸肺俞募穴　出处：《广州中医药大学》2016年硕士论文　论文类型：学位论文

【摘要】：目的：本研究通过单盲随机对照,评价艾炷灸肺俞募穴对过敏性鼻炎肺虚感寒型的临床疗效。通过本研究,推广俞募配穴在临床中的应用,为过敏性鼻炎肺虚感寒型的治疗拓展思路。方法：选取2015.01-2015.12期间合格患者70例,通过查随机数字表法随机以1：1的比例分配到实验组和对照组各35例。实验组：艾炷灸肺俞募穴,每穴3壮,每周3次,共2周。对照组：口服氯雷他定,1片,10mg, qd,共2周。在治疗前、治疗结束时与治疗结束后一月末记录患者的症状体征计分、RQLQ、TNSS、TNNSS得分。应用SPSS19.0软件包整理分析数据,从而评价艾炷灸肺俞募穴治疗过敏性鼻炎肺虚感寒型的临床疗效。结果：两组均能有效降低近期症状体征积分(总分P0.05)。实验组对降低喷嚏及流涕两项评分较显著(P0.05),对照组对降低鼻塞及鼻痒两项分数较显著(P0.05)。余无显著差异(P0.05)。两组总有效率对比P0.05,提示两组近期疗效相当。两组均能有效降低远期症状体积得分(总分P0.05),并且实验组远期疗效较好(两组组间对比总分差值P0.05)。实验组在降低喷嚏、流涕和总分的评分仍较显著(P0.05),对照组在降低鼻痒两项分数仍较显著(P0.05),余无明显差异(P0.05)。两组总有效率对比P0.05,提示两组远期疗效相当。两组均能有效降低近期及远期RQLQ、TNSS、TNNSS评分(P0.05),近期RQLQ的组间对比有显著统计学意义(P0.05),余组间对比无明显差异(P0.05),提示两组均对改善患者近期及远期鼻-结膜炎相关生活质量、鼻症状以及鼻相关症状有明显疗效,实验组对RQLQ的近期疗效较好,余两组间无明显差异。结论：综上,艾炷灸肺俞募穴对改善过敏性鼻炎肺虚感寒型流涕及喷嚏程度大于口服氯雷他定,而改善鼻塞及鼻痒程度尚有不及。两组近期疗效无显著差异,艾炷灸肺俞募穴远期疗效优于口服氯雷他定。
[Abstract]:Objective: to evaluate the clinical efficacy of moxa cone moxibustion at Feshu point in treating allergic rhinitis with deficiency of lung and cold by single blind random control. Methods: 70 eligible patients with allergic rhinitis during the period of 2015.01-2015.12 were selected. 35 cases in the experimental group and 35 cases in the control group were randomly assigned to the experimental group and the control group by the method of random number table. The experimental group was treated with moxa cone moxibustion at Feshu point, 3 strong points per acupoint, 3 times a week for 2 weeks, and the control group was treated with loratadine orally. 1 tablet 10 mg, QD for 2 weeks. The scores of symptoms and signs were recorded before, at the end of treatment and at the end of January after treatment. TNNSS score. SPSS19.0 software package was used to organize and analyze the data. So as to evaluate the clinical effect of moxa moxa moxibustion at Feshuqiu in treating allergic rhinitis with lung deficiency and cold. Results: both groups can effectively reduce the score of short-term symptoms and signs (total score P0.05). The scores of reducing sneeze and runny in the experimental group were significantly lower than those in the control group (P 0.05). In the control group, the scores of nasal congestion and nasal itching were significantly decreased (P 0.05). There was no significant difference between the two groups (P 0.05). The total effective rate of the two groups was compared with that of the control group (P0.05). The results indicated that the short-term efficacy of the two groups was the same. Both groups could effectively reduce the long-term symptom volume score (total score P0.05). And the long-term effect of the experimental group is better (the difference between the two groups compared with the total score P0.05. the score of the experimental group in reducing sneezing, runny and total score is still more significant (P0.05)). In the control group, the two scores of nasal itching were still significantly lower than that of the control group (P 0.05), but there was no significant difference between the two groups (P 0.05). The total effective rate of the two groups was compared with that of the control group (P0.05). The results indicated that the two groups had the same long-term curative effect, and both groups could effectively reduce the short-term and long-term RQLQQ / TNSS / TNNSS score (P 0.05). In recent years, there was significant statistical significance in the inter-group contrast of RQLQ, but there was no significant difference between the other groups (P0.05). The results suggest that both groups have obvious curative effects on improving the quality of life, nasal symptoms and nasal related symptoms of patients with rhinoconjunctivitis in the near and long term. The short-term curative effect of the experimental group on RQLQ is better than that of the control group. Conclusion: moxa-moxa moxibustion on lung deficiency cold type of allergic rhinitis is more serious than oral loratadine. There was no significant difference between the two groups in the short-term curative effect. The long-term curative effect of moxibustion at Feshu point was better than that of oral loratadine.
【学位授予单位】：广州中医药大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R246.81

【相似文献】